AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1514335
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (Group A) + No-treatment control (Group B)
Trial: 8370085
Drug: Floating (F)
RxNorm normalized name: Floating little wheat
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Floating (F) hydrophilic matrix capsules
Trial: 1347280
Drug: Sulphasalazine 1
RxNorm normalized name: Sulfasalazine
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulphasalazine 1 g bd
Trial: 26555602
Drug: Algisyl with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Algisyl with standard medical therapy (SMT)
Trial: 19484969
Drug: Euglycemic-hyperinsulinemic clamp
RxNorm normalized name: CLAMP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euglycemic-hyperinsulinemic clamp after 2 week insulin intensive treatment
Trial: 16118599
Drug: Metronidazole gel
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole gel
Trial: 9361167
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg twice daily (RAN)
Trial: 31060106
Drug: Activities of
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activities of Daily Living (ADL) II (disabled only in some instrumental ADL)
Trial: 27245206
Drug: Galactogogue containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galactogogue containing silymarin-phosphatidylserine and galega, 5 g/day (galactogogue group, GG)
Trial: 9846707
Drug: Vaginal PGE2
RxNorm normalized name: dinoprostone
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Vaginal PGE2 2 mg, two doses at 6-hour intervals
Trial: 26480547
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (estazolam 1mg before bed, oryzanol 20 mg three times a day) for 4 weeks
Trial: 26480547
Drug: Integrated acupuncture
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated acupuncture and medication (same as above) for 4 weeks
Trial: 10752844
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (NO)
Trial: 29134517
Drug: Subcutaneous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous ketamine 1 mg·kg‐1 (n=30)
Trial: 21124304
Drug: D-cycloserine (DCS)
RxNorm normalized name: D-Cycloserine
DrugBank: Cycloserine (DB00260)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: D-cycloserine (DCS) 1000 mg
Trial: 21124304
Drug: Glycine 0.3
RxNorm normalized name: FreAmine 6.9 (alanine 0.4 GM / arginine 0.58 GM / cysteine 0.02 GM / glycine 0.33 GM / histidine 0.16 GM / isoleucine 0.76 GM / leucine 1.37 GM / lysine (as lysine acetate) 0.58 GM / methionine 0.25 GM / phenylalanine 0.32 GM / proline 0.63 GM / serine 0.33 GM / threonine 0.2 GM / tryptophan 0.09 GM / valine 0.88 GM) per 100 ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycine 0.3 g/kg
Trial: 1773908
Drug: Dimethindene maleate
RxNorm normalized name: dimethindene maleate
DrugBank: Dimetindene (DB08801)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dimethindene maleate 6 mg
Trial: 1636805
Drug: Acute treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute treatment with imipramine (6 months)
Trial: 19691829
Drug: 7 days
RxNorm normalized name: ZINGIBER OFFICINALE (GINGER) ROOT OIL 0.006 mg in 30 mg TOPICAL LIQUID [JAYSUING 7 Days Nail Fungus Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 days of ciprofloxacin or 7 days of empirical beta-lactams +/− gentamicin intravenously with early switch to oral ciprofloxacin followed by 7 days of blinded placebo
Trial: 31377905
Drug: Intravitreal anti-VEGF
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravitreal anti-VEGF injection (bevacizumab 1.25 mg or ranibizumab 0.5 mg)
Trial: 31377905
Drug: Dexamethasone implant
RxNorm normalized name: dexamethasone Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone implant (0.7 mg)
Trial: 11912261
Drug: AMG 073
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 073 (50 mg)
Trial: 11912261
Drug: AMG 073
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 073 (100 mg)
Trial: 17921373
Drug: High-fiber cereal
RxNorm normalized name: FIBERMED HIGH-FIBER SUPPLEMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fiber cereal (HF; 33 g insoluble fiber)
Trial: 17507703
Drug: As-needed combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: As-needed combination therapy
Trial: 12911833
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 1000-2000 micro g/day
Trial: 26226139
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (4 g/d)
Trial: 12921494
Drug: Zolmitriptan nasal
RxNorm normalized name: Zolmitriptan Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan nasal spray 2.5mg
Trial: 27770454
Drug: Oral nutrition
RxNorm normalized name: BAGS/TUBES/SUPPLIES FOR ORAL NUTRITION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutrition alone (group B; n = 83)
Trial: 27770454
Drug: Postoperative total
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative total parenteral nutrition (group A; n = 74)
Trial: 18312522
Drug: Ketamine 1
RxNorm normalized name: ketamine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 1 mg x kg(‐1)
Trial: 1492226
Drug: Etoposide in
RxNorm normalized name: etoposide Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoposide in combination with anthracycline
Trial: 2179277
Drug: nicardipine 20
RxNorm normalized name: nicardipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nicardipine 20 mg tid
Trial: 12847735
Drug: Topical and
RxNorm normalized name: norgestimate and ethinylestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical and oral L-phenylalanine (100 mg/Kg/day and gel at 10%) with 0.025% clobetasol propionate at night, sunlight or UVA exposure
Trial: 27902588
Drug: Normally therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normally therapy method (Control)
Trial: 18182463
Drug: Hydrocortisone infusion
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone infusion (3 microg/kg/min for 6 hours)
Trial: 8432776
Drug: Saline control
RxNorm normalized name: GLYCERIN 0.53 g in 1 mL CUTANEOUS INJECTION [Glycerol-Saline Control]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline control infusion
Trial: 22336574
Drug: Hydrocortisone infusion
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone infusion
Trial: 21842274
Drug: frovatriptan 2.5
RxNorm normalized name: frovatriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: frovatriptan 2.5 mg
Trial: 14676459
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg CEE and 2.5 mg MPA every other day
Trial: 10525751
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg sulpiride
Trial: 27578252
Drug: Orange-flavoured beverage
RxNorm normalized name: Orange
DrugBank: Orange (DB10549)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orange-flavoured beverage with low dose OPF (2.5 g)
Trial: 27400947
Drug: Cabozantinib 60
RxNorm normalized name: cabozantinib 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabozantinib 60 mg once per day
Trial: 27400947
Drug: Prednisone 5
RxNorm normalized name: prednisone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 5 mg twice per day
Trial: 9346426
Drug: Acetazolamide (Acz)
RxNorm normalized name: Acetazolamide
DrugBank: Acetazolamide (DB00819)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetazolamide (Acz) administration
Trial: 8389536
Drug: Culture preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Culture preparations of skin specimens from primary EM patients
Trial: 8389536
Drug: Culture preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Culture preparations of skin specimens from secondary EM patients
Trial: 31954837
Drug: Stepwise CMD
RxNorm normalized name: levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Stepwise CMD risk assessment followed by individualized treatment
Trial: 29084522
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 10,000 IU daily
Trial: 2968374
Drug: Trioxsalen bath-PUVA
RxNorm normalized name: Trioxsalen
DrugBank: Trioxsalen (DB04571)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trioxsalen bath-PUVA treatment (control for methoxsalen)
Trial: 28477440
Drug: Intravitreous fluocinolone
RxNorm normalized name: Fluocinolone Acetonide Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreous fluocinolone acetonide implant
Trial: 14623061
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg tibolone
Trial: 23045348
Drug: BoNT-A injection
RxNorm normalized name: BoNT/A-DS
DrugBank: LetibotulinumtoxinA (DB16820)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BoNT-A injection into the soleus muscle
Trial: 12848776
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg DEX hydro-bromide
Trial: 12124547
Drug: Control (G-1)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (G-1)
Trial: 31307505
Drug: 3.75 mg
RxNorm normalized name: zopiclone 3.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 mg midazolam
Trial: 9603657
Drug: Systemic liarozole
RxNorm normalized name: Letrozole
DrugBank: Letrozole (DB01006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic liarozole 75 mg BID for at least 2 months
Trial: 2271089
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (6 g daily for 1 month)
Trial: 23227307
Drug: Low-dose Tacrolimus
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose Tacrolimus (LD) with EC-MPS 720mg bid
Trial: 18396035
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg morphine + 5 mg ketamine/bolus (MK group)
Trial: 3904373
Drug: Intravenous milrinone
RxNorm normalized name: Milrinone
DrugBank: Milrinone (DB00235)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous milrinone (25, 50, and 75 micrograms/kg)
Trial: 8528973
Drug: Floxuridine (FUDR)
RxNorm normalized name: Floxuridine
DrugBank: Floxuridine (DB00322)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Floxuridine (FUDR) 0.525 mg/kg/day + L-folinic acid (L-FA) 10 mg/m2/day
Trial: 25018648
Drug: Desvenlafaxine 100
RxNorm normalized name: desvenlafaxine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine 100 mg/day
Trial: 29593018
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (250 mg daily for 5 days)
Trial: 8680672
Drug: Albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol
Trial: 16104039
Drug: Aprepitant regimen
RxNorm normalized name: Aprepitant
DrugBank: Aprepitant (DB00673)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprepitant regimen (Day 1: APR 125 mg, OND 8 mg, DEX 12 mg before chemotherapy and OND 8 mg 8 hrs later; Days 2-3: APR 80 mg every day)
Trial: 23427386
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (performed three times/week from postoperative day 7 until postoperative day 21)
Trial: 15790982
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone 400 microg daily for 12 weeks
Trial: 15790982
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (non-smokers receiving inhaled beclomethasone)
Trial: 12966473
Drug: Ketorolac 30
RxNorm normalized name: ketorolac 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 30 mg intravenously
Trial: 26860802
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) treatment
Trial: 23218184
Drug: FAc implants
RxNorm normalized name: 4'-Thio-fac
DrugBank: 4'-Thio-fac (DB16071)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FAc implants
Trial: 22333199
Drug: Propofol TCI
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol TCI plus a low concentration of sevoflurane inhalation induction (Group A)
Trial: 28724657
Drug: Lipid-based nutrient
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutrient supplements (LNS-PL) 20 g/d, 118 kcal
Trial: 25199526
Drug: Physical Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical Therapy (2x/week for 6 weeks, followed by 6 weeks of monitored home exercise)
Trial: 10534727
Drug: Recombinant hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hepatitis B vaccine (20 microg/dose) given in months 0, 1, and 6 to group I (26 patients)
Trial: 24552155
Drug: Albiglutide 30
RxNorm normalized name: ALBIGLUTIDE 30MG/0.5ML INJ PEN 0.5ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albiglutide 30 mg biweekly
Trial: 14752617
Drug: Taurine supplementation
RxNorm normalized name: Taurine
DrugBank: Taurine (DB01956)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Taurine supplementation (3 g/day)
Trial: 1323160
Drug: Sodium stibogluconate
RxNorm normalized name: sodium stibogluconate
DrugBank: Sodium stibogluconate (DB05630)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium stibogluconate combined with oral verapamil
Trial: 1093604
Drug: Topical cephaloridine
RxNorm normalized name: cephaloridine
DrugBank: Cefaloridine (DB09008)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cephaloridine
Trial: 19168019
Drug: Desmopressin tablets
RxNorm normalized name: desmopressin Sublingual Tablet
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Desmopressin tablets (0.2 or 0.4 mg)
Trial: 11719353
Drug: G-BM
RxNorm normalized name: Glatiramer Acetate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: G-BM
Trial: 28319696
Drug: Physical activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical activity without treatment rationale
Trial: 28319696
Drug: Physical activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical activity with treatment rationale
Trial: 23475289
Drug: Isoflavone 70
RxNorm normalized name: Soy isoflavones
DrugBank: Soy isoflavones (DB14101)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavone 70 mg/day for 12 weeks
Trial: 30993350
Drug: Deep extubation
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep extubation in the lateral position (group L)
Trial: 12474549
Drug: Hormone-replacement therapy
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone-replacement therapy (HRT)
Trial: 17259872
Drug: HA vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA vaccine (HAVRIX; Glaxo SmithKline) 720 EL.U., administered in group 2 at ages 12 and 18 months
Trial: 17259872
Drug: HA vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA vaccine (HAVRIX; Glaxo SmithKline) 720 EL.U., administered in group 3 at ages 15 and 21 months
Trial: 8030449
Drug: Combined hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined hormonal oral contraceptive containing 75 μg gestodene plus 30 μg ethinyl estradiol
Trial: 19399705
Drug: Low-dose (LD)
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose (LD) nifedipine; 10 mg, up to four doses every 15 minutes, daily 60 to 80 mg slow-release nifedipine for 48 hours followed by 60 mg daily until 36 weeks
Trial: 27101674
Drug: Montelukast sodium
RxNorm normalized name: Montelukast Sodium
DrugBank: Montelukast (DB00471)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Montelukast sodium tablets combined with budesonide nasal spray and desloratadine citrate disodium tablets for 4 weeks
Trial: 8198235
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with alginate-conjugated extract of Parietaria judaica
Trial: 27979383
Drug: Docetaxel 75
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 75 mg/m2 every 3 weeks
Trial: 21953376
Drug: 1.6 g
RxNorm normalized name: GLYCERIN 1241.6 g in 1 L TOPICAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.6 g CMC-001 (manganese-based contrast agent)
Trial: 2365458
Drug: Leish vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leish vaccine 5
Trial: 28387919
Drug: Intensive drugs
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive drugs (Control)
Trial: 8910180
Drug: Lidocaine 30
RxNorm normalized name: lidocaine 30 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 30 mg
Trial: 23223105
Drug: Lidocaine 45
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine 45 mg
Trial: 12399193
Drug: MPL-containing vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPL-containing vaccine
Trial: 9794569
Drug: Nifedipine retard
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine retard (10‐40 mg twice daily)
Trial: 7655643
Drug: Octreotide (OCT)
DrugBank: Octreotide (DB00104)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Octreotide (OCT) administration (300 to 600 micrograms/day for 1 month)
Trial: 15377319
Drug: SB-220453 40
RxNorm normalized name: SBS-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-220453 40 mg
Trial: 31586667
Drug: Oral amoxicillin
RxNorm normalized name: amoxicillin Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amoxicillin
Trial: 21727006
Drug: Ibandronate 6
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 6 mg infused over 60 min
Trial: 7604951
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray 200 micrograms once daily
Trial: 14998068
Drug: Naratriptan 1
RxNorm normalized name: naratriptan 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naratriptan 1 mg
Trial: 24717626
Drug: Tadalafil 10
RxNorm normalized name: tadalafil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 10 mg daily for 12 weeks
Trial: 1097470
Drug: Minocycline 100
RxNorm normalized name: minocycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline 100 mg twice daily
Trial: 1097470
Drug: Tetracycline 250
RxNorm normalized name: tetracycline 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetracycline 250 mg six-hourly
Trial: 28083972
Drug: SGLT2 inhibitors
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SGLT2 inhibitors (including canagliflozin, dapagliflozin, empagliflozin)
Trial: 27325864
Drug: Regorafenib 160
RxNorm normalized name: Regorafenib
DrugBank: Regorafenib (DB08896)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Regorafenib 160 mg orally on days 1 to 21 of each 28-day cycle until disease progression or prohibitive adverse events occurred.